Study Title
Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
Study Details
Description:
This clinical trial will evaluate the safety of Cabazitaxel in combination with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer.
Sponsor:
Peter MacCallum Cancer Centre
Contacts:
Gaurav Sharmagaurav.sharma@petermac.org
03 85596830
Dr Louise Kostoslouise.kostos@petermac.org
Government Study Link:
NCT05340374 - Click here to see study onClinicalTrials.gov